| 000 | 01867 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513103644.0 | ||
| 264 | 0 | _c19970213 | |
| 008 | 199702s 0 0 eng d | ||
| 022 | _a0269-2813 | ||
| 024 | 7 |
_a10.1046/j.1365-2036.1996.54196000.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpadaccini, A | |
| 245 | 0 | 0 |
_aOmeprazole versus ranitidine: short-term triple-therapy in patients with Helicobacter pylori-positive duodenal ulcers. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cOct 1996 |
||
| 300 |
_a829-31 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Ulcer Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntitrichomonal Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 |
_aClarithromycin _xadministration & dosage |
| 650 | 0 | 4 |
_aDuodenal Ulcer _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHelicobacter Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHelicobacter pylori _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOmeprazole _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRanitidine _xadministration & dosage |
| 650 | 0 | 4 |
_aTinidazole _xadministration & dosage |
| 700 | 1 | _aDe Fanis, C | |
| 700 | 1 | _aSciampa, G | |
| 700 | 1 | _aMasciulli, V | |
| 700 | 1 | _aPantaleone, U | |
| 700 | 1 | _aDi Virgilio, M | |
| 700 | 1 | _aMagnarini, C | |
| 700 | 1 | _aPizzicannella, G | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 10 _gno. 5 _gp. 829-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2036.1996.54196000.x _zAvailable from publisher's website |
| 999 |
_c8891662 _d8891662 |
||